Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET 

Rhea-AI Summary

Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its fourth-quarter financial results for the period ending December 31, 2022, before market open on March 9, 2023. The company will also host a conference call at 8:00 a.m. Eastern Time to discuss these results. Participants wishing to ask questions during the call must register in advance to receive dial-in information. The earnings release and accompanying slide presentation will be accessible on the company's Investor Relations website. Harvard Bioscience specializes in developing technologies and products for life sciences, serving a diverse range of clients globally.

HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on March 9, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. 

Participants who want to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number. 

Participants who want to join the audio-only webcast should go to our events and presentations on the investor website here.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website. 

About Harvard Bioscience 

Harvard Bioscience, Inc., a Delaware corporation, is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe and China, we sell through a combination of direct and distribution channels to customers around the world. 

For more information, please visit our website at www.harvardbioscience.com. 

Investor Contact 
Jennifer Cote 
Interim Chief Financial Officer 
(508) 893-8999

 

FAQ

When will Harvard Bioscience announce its fourth-quarter results for 2022?

Harvard Bioscience will announce its fourth-quarter financial results on March 9, 2023.

What time is the Harvard Bioscience conference call regarding its financial results?

The conference call will be held at 8:00 a.m. Eastern Time on March 9, 2023.

How can I participate in the Harvard Bioscience earnings call?

To participate and ask questions during the call, you must register in advance to receive the necessary dial-in details.

Where can I find the financial information related to Harvard Bioscience's earnings?

The financial information, including the earnings release and presentation, will be available on Harvard Bioscience's Investor Relations website.